ORIC PHARMACEUTICALS, INC.
ORIC US68622P1093
🆔
Registration No.
5595382
💰
Capitalization
Small-cap
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
🔗
Website
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -56% | -63% | 54% | -12% | 4% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
📊
Transactions
27
🙍
Insiders
4
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Chacko Jacob CEO |
12.32 USD |
37,461 Sold |
461,520 USD |
06/10/2025 | 06/10/2025 |
| Piscitelli Dominic CFO |
14.52 USD |
11,000 Sold |
159,719 USD |
06/10/2025 | 06/10/2025 |
| Chacko Jacob CEO |
12.05 USD |
53,001 Sold |
638,805 USD |
30/09/2025 | 01/10/2025 |
| Chacko Jacob CEO |
12.01 USD |
34,538 Sold |
414,750 USD |
30/09/2025 | 30/09/2025 |
| Chacko Jacob CEO |
10.80 USD |
125,000 Sold |
1,349,938 USD |
22/09/2025 | 22/09/2025 |
| Piscitelli Dominic CFO |
10.05 USD |
20,000 Sold |
200,972 USD |
01/07/2025 | 01/07/2025 |
| Piscitelli Dominic CFO |
10.50 USD |
32,466 Sold |
341,039 USD |
23/06/2025 | 24/06/2025 |
| You Angie O |
9.43 USD |
1,403 Bought |
13,230 USD |
20/06/2025 | 23/06/2025 |
| Piscitelli Dominic CFO |
10.00 USD |
584 Sold |
5,840 USD |
23/06/2025 | 23/06/2025 |
| Piscitelli Dominic CFO |
10.01 USD |
450 Sold |
4,505 USD |
23/06/2025 | 23/06/2025 |